本页面由Tiger Trade Technology Pte. Ltd.提供服务

Viridian Therapeutics, Inc.

32.02
-0.4400-1.36%
盘后31.15-0.8749-2.73%18:05 EST
成交量:67.38万
成交额:2,164.99万
市值:30.56亿
市盈率:-10.60
高:32.97
开:32.44
低:31.95
收:32.46
52周最高:33.34
52周最低:9.90
股本:9,544.20万
流通股本:8,072.30万
量比:0.59
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-3.0205
每股收益(LYR):-3.0722
净资产收益率:-49.89%
总资产收益率:-30.08%
市净率:9.73
市盈率(LYR):-10.42

数据加载中...

2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/18

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/10

重要事件披露

Form 8-K - Current report
2024/08/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]